Results 151 to 160 of about 108,169 (285)

Effectiveness and Safety of Interventions for Sarcopenia in Advanced Prostate Carcinoma: Systematic Review

open access: yesJournal of Cachexia, Sarcopenia and Muscle, Volume 17, Issue 3, June 2026.
ABSTRACT Background Sarcopenia has emerged as a potential prognostic factor in patients with advanced prostate cancer (PCa), requiring interventions for its prevention and treatment. Objective We aimed to systematically identify, critically assess and synthesize the available evidence on the effectiveness and safety of interventions for preventing or ...
Pedro de Pablos‐Rodríguez   +8 more
wiley   +1 more source

Validity of Bioelectrical Impedance Analysis for the Assessment of Body Composition in Patients With Systemic Sclerosis. [PDF]

open access: yesJ Cachexia Sarcopenia Muscle
Dória LD   +15 more
europepmc   +1 more source

Elevated Circulating Ceramides 18:0 and 24:1 as a Risk Factor for Sarcopenia: In Vitro, Animal, and Clinical Evidence

open access: yesJournal of Cachexia, Sarcopenia and Muscle, Volume 17, Issue 3, June 2026.
ABSTRACT Background Ceramides have garnered considerable attention as pro‐aging bioactive lipids implicated in both metabolic dysfunction and musculoskeletal decline. Among these, C18:0 and C24:1 ceramides may play a role in the pathophysiology of sarcopenia, a key manifestation of age‐related deterioration.
So Jeong Park   +15 more
wiley   +1 more source

Exploratory XPS Evidence for Ca–N Environments at the Organic–Mineral Interface in Bone

open access: yesSurface and Interface Analysis, Volume 58, Issue 6, Page 369-374, June 2026.
ABSTRACT Bone derives its remarkable mechanical properties from the nanoscale relationship between its organic matrix and mineral components. While interfacial interactions are known to affect bone mechanics, direct evidence of chemical bonding at this interface has been lacking.
Richard Leslie Abel   +3 more
wiley   +1 more source

SEMASEARCH Study Design: Real‐World Evaluation of Semaglutide 2.4 mg in Adults With Severe Obesity Underrepresented in Clinical Trials

open access: yesDiabetes, Obesity and Metabolism, Volume 28, Issue 6, Page 4602-4609, June 2026.
ABSTRACT Background Although semaglutide 2.4 mg has demonstrated significant weight loss efficacy in clinical trials, real‐world data, particularly with regard to clinically complex and underrepresented populations, remain limited. Objectives The study aims to assess the real‐world effectiveness and patient‐reported outcomes associated with the use of ...
Pierre Bel Lassen   +20 more
wiley   +1 more source

Defining Obesity Under the Lancet Commission Criteria: Metabolic Syndrome–Anchored Body Fat Percentage Thresholds in Korean Adults

open access: yesDiabetes, Obesity and Metabolism, Volume 28, Issue 6, Page 5309-5317, June 2026.
ABSTRACT Aims The revised Lancet Commission framework prioritizes excess adiposity over body mass index (BMI) alone for diagnosing obesity, emphasizing population‐specific body fat assessments. However, body fat percentage (BFP) thresholds reflecting adiposity‐defined obesity remain limited, particularly by sex and age in Asian populations.
Han Na Jung   +8 more
wiley   +1 more source

Estimación de la masa grasa por DXA y el modelo de cuatro compartimentos en púberes mexicanos de 9 a 14 años

open access: yesArchivos Latinoamericanos de Nutrición
Se evaluó la precisión y exactitud en la estimación de la grasa corporal (%) por absorciometría dual de rayos X (DXA Lunar-DPX-MD) comparado con el modelo de cuatro compartimentos (4C) en 32 púberes (F=16) de 9 a 14 años.
Erik Ramírez   +4 more
doaj  

Home - About - Disclaimer - Privacy